Log In / Sign Up

HB 2529

  • Texas House Bill
  • 88th Legislature (2023)
  • Introduced in House Mar 13, 2023
  • House
  • Senate
  • Governor

Relating to written notification provided by drug manufacturers regarding the cause of generic insulin prescription drug unavailability.

View Latest Bill Text
Sign In to Follow

Bill Subjects

Diabetes (S0486) Health & Human Services Commission (V0177) Health--Other Diseases & Medical Conditions (I0383) Insurance--Health & Accident (I0422) Medicine & Prescription Drugs (S7338)

Abstract

Bill Sponsors (1)

James Talarico

  • Democratic
  • Representative
  • District 50
Primary

Votes

No votes to display

Actions

May 01, 2023

House

Considered in public hearing

House

Testimony taken/registration(s) recorded in committee

House

Left pending in committee

Mar 13, 2023

House

Read first time

House

Referred to Public Health

  • Referral-Committee
Public Health

Feb 21, 2023

House

Filed

Bill Text

Bill Text Versions Format
Introduced PDF HTML

Related Documents

Document Format
Fiscal Note (Introduced) HTML

Sources

Data on Open States is updated periodically throughout the day from the official website of the Texas Legislature.

If you notice any inconsistencies with these official sources, feel free to file an issue.